SNRS news

Latest 1 stories · newest Sep 23, 2026

SNRS

Xenetic Biosciences releases investor presentation with a proposed transaction

Xenetic Biosciences has filed an exhibit containing a proposed transaction discussion and forward-looking statements, with both companies targeting a Nasdaq listing post-merger.

M&A Sep 23, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same SNRS feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/SNRS/newsSTART FREE